chemotherapy agents and independent double checks?

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

4 posts / 0 new
Last post
Tamra M Pierce
Tamra M Pierce's picture
Offline
Last seen: 5 days 16 hours ago
Joined: 04/10/2023 - 08:49
chemotherapy agents and independent double checks?

Hello all,

The medication safety team at our site wanted to look and see which specific cancer medications are high alert and therefore require independent double checks. The ISMP list of high-alert medications includes chemotherapeutic agents which seems to encompass all cancer medications (chemotherapy, monoclonal antibodies, tyrosine kinase inhibitors, etc.) Does anyone have any resources or insight as to whether immunotherapies such as MABs and TKIs are included in the umbrella term “chemotherapeutic agent”? Our goal is to determine whether we are doing independent double checks on medications that may not require them, thus worsening the burden that is put on our nursing staff. Thank you for your help in advance!

Tamra Pierce, PharmD, BCPS
Medication Safety Pharmacist
Veterans Health Indiana